VAERS Datenanalyse und Statistik
VAERS DatenanalyseSuche nach Chargen, Symptomen, Reports und Statistiken
Zurueck zur Suche

Reporte zur Charge 3Y7NL

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 2 ID 2 IN 1 KY 1 CA 1 GA 1 WA 1 WI 1 UT 1 NC 1

VAERS 1124703

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

schwer
Staat
-
Alter
19,0
Geschlecht
M
Eingang
22.03.2021
Impfdatum
23.03.2021
Beginn
23.03.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Presyncope

Symptomtext

Patient had vasovagal after receiving vaccinations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1230035

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

mild
Staat
IN
Alter
44,0
Geschlecht
F
Eingang
19.04.2021
Impfdatum
16.04.2021
Beginn
16.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Diarrhoea Fatigue Hypoaesthesia Immediate post-injection reaction Oedema

Symptomtext

Immediate numbness and weakness in RUE. Immediate edema RUE. Diarrhea and fatigue within 8 hours and lasting 48 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Shellfish PCN Sulfa
Vorherige Impfungen
-

VAERS 1129653

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

mild
Staat
KY
Alter
61,0
Geschlecht
F
Eingang
24.03.2021
Impfdatum
10.03.2021
Beginn
10.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Malaise

Symptomtext

felt faint; felt faint and ill; This case was reported by a consumer via call center representative and described the occurrence of felt faint in a 61-year-old female patient who received HAB (Twinrix) (batch number 3Y7NL, expiry date 24th May 2022) for prophylaxis. Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 10th March 2021, the patient received Twinrix (intramuscular) and Twinrix Pre-Filled Syringe Device. On 10th March 2021, less than a day after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced felt faint (serious criteria GSK medically significant) and feeling unwell. On an unknown date, the outcome of the felt faint and feeling unwell were recovered/resolved. It was unknown if the reporter considered the felt faint and feeling unwell to be related to Twinrix and Twinrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The age at vaccination was not reported. After being vaccinated the patient felt faint and ill. The patient was transported to the emergency department (ED). Symptoms have since resolved. The reporter did not consent to follow-up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1092671

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

mild
Staat
CA
Alter
61,0
Geschlecht
F
Eingang
11.03.2021
Impfdatum
10.03.2021
Beginn
10.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Malaise

Symptomtext

Pt was given vaccination for hepatitis A and hepatitis B combination. Pt had previous vaccines like flu in past with no issues. Pt had COVID vaccine in January with no issues. Injection site immediately after administration had no reaction whatsoever . Patient mentioned that she did not even feel the vaccine pain. After immunization, patient complained of "not feeling too well' and told pharmacist and husband this. She asked for water which was given to her. She was in chair and her husband sat next to her. She then asked for paramedic to be called. Paramedics were called and they came and took her vitals. She was then ferried on gurney and paramedics said they would take her to Hospital. Patient was apologizing to pharmacist and staff for the situation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 922119

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

mild
Staat
GA
Alter
53,0
Geschlecht
F
Eingang
05.01.2021
Impfdatum
04.01.2021
Beginn
04.01.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal discomfort Erythema Pruritus

Symptomtext

Individual was given vaccine at 10:00 am. AT 10:40 am after receiving the vaccine individual developed itchy and reddened left forearm and stomach Individual vitals were stable. Individual went home after waiting 45 mins. with no noted distress.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2299577

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

gering
Staat
ID
Alter
40,0
Geschlecht
F
Eingang
28.05.2022
Impfdatum
25.05.2022
Beginn
25.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

expired vaccine applied; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 40-year-old female patient who received HAB (Twinrix) (batch number 3Y7NL, expiry date 24th May 2022) for prophylaxis. Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 25th May 2022, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 25th May 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was recovered/resolved. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-May-2022 Reporter's Comments: The health care professional stated they gave a patient an expired vaccine. The reporter consented to follow up. The Vaccine Administration Facility is the same as Primary Reporter. Additional Supportive Information: The patient received Twinrix which was already expired which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2294796

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

gering
Staat
ID
Alter
40,0
Geschlecht
M
Eingang
25.05.2022
Impfdatum
25.05.2022
Beginn
25.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

No adverse event. Expired vaccine was given. Pt presented in office today for blood work and to receive 2nd dose of the Twinrix. Pt was given immunization with the exp date of 05/24/22. CDC has been contacted and advised that most expired vaccines usually need to be regiven. They also advised that contacting glaxo smith to see if there is a grace period that the immunization can still be valid. Contacted Glaxo Smith and was advised GSK has not evaluated the immunogenicity or safety following the administration of an expired vaccine dose. GSK does not make recommendations regarding revaccination or serologic testing following inadvertent administration of an expired vaccine dose. Based on analysis and potency testing, the vaccine remains within the approved specifications until a maximum of 30 days following the expiration date as written on the vaccine package,if stored under appropriate temperature and storage conditions as described in the Prescribing Information.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
HIV
Vorgeschichte
HIV
Andere Medikamente
albuterol, clindamycin, clotrimazole, emtricitabine 200mg-tenofovir disoproxil fumarate 300 mg, hydrocortisone 2.5% topical cream, hydroxyzine HCL 25 mg, Konsyl powder, Paxlovid 300 mg, Sertraline 50 mg, sulfamethoxazole 800 mg- trimethopri
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2158577

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

gering
Staat
WA
Alter
32,0
Geschlecht
M
Eingang
04.03.2022
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Wrong vaccine administered through mis-identified patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1938307

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3y7nL

gering
Staat
IL
Alter
58,0
Geschlecht
F
Eingang
10.12.2021
Impfdatum
22.12.2020
Beginn
22.12.2020
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

received 2 Twinrix instead of 2 Energix; received 2 Twinrix instead of 2 Energix; This case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 59-year-old female patient who received HAB (Twinrix) (batch number 3y7nL, expiry date 24th May 2022) for prophylaxis. Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAB (Twinrix) (batch number 9355d, expiry date 14th March 2022) for prophylaxis and hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included HEPATITIS B VACCINE (ENGERIX B). On 1st June 2021, the patient received the 2nd dose of Twinrix (intramuscular) 1 ml and Twinrix Pre-Filled Syringe Device. On 22nd December 2020, the patient received the 1st dose of Twinrix (intramuscular) 1 ml and Twinrix Pre-Filled Syringe Device. On 22nd December 2020, not applicable after receiving Twinrix and Twinrix Pre-Filled Syringe Device, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device and 36 days after receiving ENGERIX B, the patient experienced wrong vaccine administered. On 1st June 2021, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received 2 dose of Twinrix instead of 2 dsoe of Engerix B, which led to wrong vaccine administered. The patient was told that needed to get Havrix in order to be vaccinated against Hepatitis A. The reporter was asking about the dosing schedule for giving this vaccine. The reporter did not consent to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1580077

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

gering
Staat
WI
Alter
14,0
Geschlecht
M
Eingang
18.08.2021
Impfdatum
06.08.2021
Beginn
06.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

14 year old / received / Twinrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 14-year-old male patient who received HAB (Twinrix) (batch number 3Y7NL, expiry date 24th May 2022) for prophylaxis. Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th August 2021, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 6th August 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided are as follows: A14 year old patient received a dose of Twinrix, which led to inappropriate age at vaccine administration. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow-up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1456608

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3y7nl

gering
Staat
IL
Alter
61,0
Geschlecht
M
Eingang
08.07.2021
Impfdatum
30.06.2021
Beginn
30.06.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

patient received 2nd dose of twinrix late; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 61-year-old male patient who received HAB (Twinrix) (batch number 3y7nl, expiry date 24th May 2022) for prophylaxis. Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Twinrix (1st dose received on 20th September 2020). On 30th June 2021, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 30th June 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: This case was reported by a registered pharmacist. The patient received 2nd dose of Twinrix later then the recommended schedule, which led to lengthening of vaccination schedule. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1291577

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

gering
Staat
UT
Alter
53,0
Geschlecht
F
Eingang
06.05.2021
Impfdatum
23.04.2021
Beginn
23.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Patient received dose two / late / First dose 12.28.20 - Second dose 4/23/21; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 53-year-old female patient who received HAB (Twinrix) (batch number 3Y7NL, expiry date 24th May 2022) for prophylaxis. Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Twinrix (received 1st dose on 28th December 2020). On 23rd April 2021, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 23rd April 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported the patient received dose two of Twinrix longer than recommended interval, which led to lengthening of vaccination schedule. Lot number and expiration date for dose 1 of Twinrix were not provided. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1267502

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

gering
Staat
NC
Alter
1,6
Geschlecht
F
Eingang
28.04.2021
Impfdatum
01.12.2020
Beginn
01.12.2020
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Upon the patient coming to the clinic on 4/27/2021, it was found that the RN had given the patient a Kinrix vaccine on 12/01/2020 which is indicated for 4-6 year olds and a Twinrix vaccine on 11/02/2021 that is for ages 18 years and older, and the patient was only 1 year and 6 months old at the time. The patients mother stated she did not have any reaction or problems after receiving the vaccine. After talking with the NC Immunization branch, regarding future doses, it was deemed that a report needed to be made.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
none known
Vorherige Impfungen
-

VAERS 1168877

GLAXOSMITHKLINE BIOLOGICALS · HEP A + HEP B (TWINRIX) · Charge 3Y7NL

gering
Staat
-
Alter
61,0
Geschlecht
M
Eingang
05.04.2021
Impfdatum
11.03.2021
Beginn
11.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incomplete course of vaccination No adverse event

Symptomtext

Late for the third dose / First dose on January 30 2020 / Second dose on March 11 2020; Late for the third dose /First dose on January 30 2020 / Second dose on March 11 2020; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 61-year-old male patient who received HAB (Twinrix) (batch number 3Y7NL, expiry date 24th May 2022) for prophylaxis. Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAB (Twinrix) for prophylaxis and hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Twinrix adult (1st dose received on 30th January 2020). On 11th March 2021, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, the patient received the 3rd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 11th March 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device and not applicable after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the drug dose administration interval too long and incomplete course of vaccination were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received 2nd dose later than the recommended interval, which led to lengthening of vaccination schedule. Till the time of reporting patient was late for 3rd dose of Twinrix which led to incomplete course of vaccination. No adverse event was reported. The reporter did not consent to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incomplete course of vaccination
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-